BACKGROUND: The role of estrogen and progesterone in the development of endometrial cancer is well documented. Few studies have examined the association of genetic variants in sex hormone-related genes with endometrial cancer risk. METHODS: We conducted a case-control study nested within three cohorts to examine the association of endometrial cancer risk with polymorphisms in hormone-related genes among 391 cases (92% postmenopausal at diagnosis) and 712 individually-matched controls. We also examined the association of these polymorphisms with circulating levels of sex hormones and SHBG in a cross-sectional analysis including 596 healthy postmenopausal women at blood donation (controls from this nested case-control study and from a nested case-control study of breast cancer in one of the three cohorts). RESULTS: Adjusting for endometrial cancer risk factors, the A allele of rs4775936 in CYP19 was significantly associated (OR(per allele)=1.22, 95% CI=1.01-1.47, p(trend)=0.04), while the T allele of rs10046 was marginally associated with increased risk of endometrial cancer (OR(per allele)=1.20, 95% CI=0.99-1.45, p(trend)=0.06). PGR rs1042838 was also marginally associated with risk (OR(per allele)=1.25, 95% CI=0.96-1.61, p(trend)=0.09). No significant association was found for the other polymorphisms, i.e. CYP1B1 rs1800440 and rs1056836, UGT1A1 rs8175347, SHBG rs6259 and ESR1 rs2234693. Rs8175347 was significantly associated with postmenopausal levels of estradiol, free estradiol and estrone and rs6259 with SHBG and estradiol. CONCLUSION: Our findings support an association between genetic variants in CYP19, and possibly PGR, and risk of endometrial cancer.
BACKGROUND: The role of estrogen and progesterone in the development of endometrial cancer is well documented. Few studies have examined the association of genetic variants in sex hormone-related genes with endometrial cancer risk. METHODS: We conducted a case-control study nested within three cohorts to examine the association of endometrial cancer risk with polymorphisms in hormone-related genes among 391 cases (92% postmenopausal at diagnosis) and 712 individually-matched controls. We also examined the association of these polymorphisms with circulating levels of sex hormones and SHBG in a cross-sectional analysis including 596 healthy postmenopausal women at blood donation (controls from this nested case-control study and from a nested case-control study of breast cancer in one of the three cohorts). RESULTS: Adjusting for endometrial cancer risk factors, the A allele of rs4775936 in CYP19 was significantly associated (OR(per allele)=1.22, 95% CI=1.01-1.47, p(trend)=0.04), while the T allele of rs10046 was marginally associated with increased risk of endometrial cancer (OR(per allele)=1.20, 95% CI=0.99-1.45, p(trend)=0.06). PGR rs1042838 was also marginally associated with risk (OR(per allele)=1.25, 95% CI=0.96-1.61, p(trend)=0.09). No significant association was found for the other polymorphisms, i.e. CYP1B1rs1800440 and rs1056836, UGT1A1rs8175347, SHBG rs6259 and ESR1 rs2234693. Rs8175347 was significantly associated with postmenopausal levels of estradiol, free estradiol and estrone and rs6259 with SHBG and estradiol. CONCLUSION: Our findings support an association between genetic variants in CYP19, and possibly PGR, and risk of endometrial cancer.
Authors: Sabina Rinaldi; Annabelle Geay; Henri Déchaud; Carine Biessy; Anne Zeleniuch-Jacquotte; Arslan Akhmedkhanov; Roy E Shore; Elio Riboli; Paolo Toniolo; Rudolf Kaaks Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-10 Impact factor: 4.254
Authors: Monica McGrath; Susan E Hankinson; Lori Arbeitman; Graham A Colditz; David J Hunter; Immaculata De Vivo Journal: Carcinogenesis Date: 2003-12-04 Impact factor: 4.944
Authors: Alison M Dunning; Mitch Dowsett; Catherine S Healey; Louise Tee; Robert N Luben; Elizabeth Folkerd; Karen L Novik; Livia Kelemen; Saeko Ogata; Paul D P Pharoah; Douglas F Easton; N E Day; Bruce A J Ponder Journal: J Natl Cancer Inst Date: 2004-06-16 Impact factor: 13.506
Authors: Yannick Duguay; Monica McGrath; Johanie Lépine; Jean-François Gagné; Susan E Hankinson; Graham A Colditz; David J Hunter; Marie Plante; Bernard Têtu; Alain Bélanger; Chantal Guillemette; Immaculata De Vivo Journal: Cancer Res Date: 2004-02-01 Impact factor: 12.701
Authors: Shelley S Tworoger; Jessica Chubak; Erin J Aiello; Cornelia M Ulrich; Charlotte Atkinson; John D Potter; Yutaka Yasui; Patricia L Stapleton; Johanna W Lampe; Federico M Farin; Frank Z Stanczyk; Anne McTiernan Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-01 Impact factor: 4.254
Authors: Immaculata De Vivo; Gordon S Huggins; Susan E Hankinson; Pamela J Lescault; Marike Boezen; Graham A Colditz; David J Hunter Journal: Proc Natl Acad Sci U S A Date: 2002-09-06 Impact factor: 11.205
Authors: Annekatrin Lukanova; Eva Lundin; Andrea Micheli; Alan Arslan; Pietro Ferrari; Sabina Rinaldi; Vittorio Krogh; Per Lenner; Roy E Shore; Carine Biessy; Paola Muti; Elio Riboli; Karen L Koenig; Mortimer Levitz; Pär Stattin; Franco Berrino; Göran Hallmans; Rudolf Kaaks; Paolo Toniolo; Anne Zeleniuch-Jacquotte Journal: Int J Cancer Date: 2004-01-20 Impact factor: 7.396
Authors: Rachel Sparks; Cornelia M Ulrich; Jeannette Bigler; Shelley S Tworoger; Yutaka Yasui; Kumar B Rajan; Peggy Porter; Frank Z Stanczyk; Rachel Ballard-Barbash; Xiaopu Yuan; Ming Gang Lin; Lynda McVarish; Erin J Aiello; Anne McTiernan Journal: Breast Cancer Res Date: 2004-06-29 Impact factor: 6.466
Authors: A Zeleniuch-Jacquotte; R E Shore; K L Koenig; A Akhmedkhanov; Y Afanasyeva; I Kato; M Y Kim; S Rinaldi; R Kaaks; P Toniolo Journal: Br J Cancer Date: 2004-01-12 Impact factor: 7.640
Authors: Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano Journal: Front Pharmacol Date: 2018-09-19 Impact factor: 5.810
Authors: Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Christina M Pinkston; Shesh N Rai; Elizabeth C Riley; Lisa M Hines; Anna R Giuliano; Esther M John; Mariana C Stern; Gabriela Torres-Mejía; Roger K Wolff; Martha L Slattery Journal: Cancer Causes Control Date: 2014-08-05 Impact factor: 2.506
Authors: Tess V Clendenen; Justin Rendleman; Wenzhen Ge; Karen L Koenig; Isaac Wirgin; Diane Currie; Roy E Shore; Tomas Kirchhoff; Anne Zeleniuch-Jacquotte Journal: PLoS One Date: 2015-08-14 Impact factor: 3.240
Authors: Tess Clendenen; Anne Zeleniuch-Jacquotte; Isaac Wirgin; Karen L Koenig; Yelena Afanasyeva; Eva Lundin; Alan A Arslan; Tomas Axelsson; Asta Försti; Göran Hallmans; Kari Hemminki; Per Lenner; Nirmal Roy; Roy E Shore; Yu Chen Journal: PLoS One Date: 2013-07-23 Impact factor: 3.240
Authors: Deborah J Thompson; Tracy A O'Mara; Dylan M Glubb; Jodie N Painter; Timothy Cheng; Elizabeth Folkerd; Deborah Doody; Joe Dennis; Penelope M Webb; Maggie Gorman; Lynn Martin; Shirley Hodgson; Kyriaki Michailidou; Jonathan P Tyrer; Mel J Maranian; Per Hall; Kamila Czene; Hatef Darabi; Jingmei Li; Peter A Fasching; Alexander Hein; Matthias W Beckmann; Arif B Ekici; Thilo Dörk; Peter Hillemanns; Matthias Dürst; Ingo Runnebaum; Hui Zhao; Jeroen Depreeuw; Stefanie Schrauwen; Frederic Amant; Ellen L Goode; Brooke L Fridley; Sean C Dowdy; Stacey J Winham; Helga B Salvesen; Jone Trovik; Tormund S Njolstad; Henrica M J Werner; Katie Ashton; Tony Proietto; Geoffrey Otton; Luis Carvajal-Carmona; Emma Tham; Tao Liu; Miriam Mints; Rodney J Scott; Mark McEvoy; John Attia; Elizabeth G Holliday; Grant W Montgomery; Nicholas G Martin; Dale R Nyholt; Anjali K Henders; John L Hopper; Nadia Traficante; Matthias Ruebner; Anthony J Swerdlow; Barbara Burwinkel; Hermann Brenner; Alfons Meindl; Hiltrud Brauch; Annika Lindblom; Diether Lambrechts; Jenny Chang-Claude; Fergus J Couch; Graham G Giles; Vessela N Kristensen; Angela Cox; Manjeet K Bolla; Qin Wang; Stig E Bojesen; Mitul Shah; Robert Luben; Kay-Tee Khaw; Paul D P Pharoah; Alison M Dunning; Ian Tomlinson; Mitch Dowsett; Douglas F Easton; Amanda B Spurdle Journal: Endocr Relat Cancer Date: 2015-11-16 Impact factor: 5.678